Triiodated isophthalamide x-ray contrast agents

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/36, 260/550.

C07D 209/48 (2006.01)

Patent

CA 1129438

ABSTRACT The invention provides a compound of the general formula Image (I) in which X represents an unsubstituted or substituted lower alkylene radical, R represents a hydrogen atom or a lower alkyl radical, R represents a hydrogen atom, a lower alkyl radical or a lower mono- or poly- hydroxyalkyl radical, R3 represents a hydrogen atom, a lower alkyl radi- cal or a lower mono- or poly- hydroxyalkyl radical, R4 represents a hydrogen atom, a lower alkyl radical or a lower mono- or poly- hydroxyalkyl radical, R5 represents a lower mono- or poly-hydroxyalkyl radical, R6 represents a hydrogen atom, a lower alkyl radi- cal or a lower mono- or poly- hydroxyalkyl radical, R7 represents a lower mono- or poly-hydroxyalkyl radical, salts thereof, processes for their preparation and use as X-ray contrast agents. Preferred salts are those with contrast agent acids. These salts are stable and excellently tolerable. Their solutions have low viscos- ity and therefore highly concentrated but nevertheless readily injectable X-ray contrast agent solutions can be manufactured.

355900

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Triiodated isophthalamide x-ray contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triiodated isophthalamide x-ray contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triiodated isophthalamide x-ray contrast agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-654794

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.